Charles River - JP Morgan Conference Presentation
Safety Assessment Supply Chain Update
- Both small and large research models are required for use in regulated drug safety testing by the U.S. Food and
Drug Administration and other international regulatory agencies
Non-human primates (NHPs) are the most scientifically relevant large model for critical translational research for biologic drugs
- NHPs have been in high demand in recent years due to a significant increase in biologic drug development activity
-
NHP supply remains a fluid situation that we are continuing to work through
- CRL continues to work diligently on the diversification of its NHP supply chain
- CRL intends to provide a broader update on the status of NHP shipments and supply for 2023 when we issue 2023
financial guidance in mid/late February
Charles River - JP Morgan Conference Presentation
13View entire presentation